SCHEMBL15340536

SCHEMBL15340536

COc1ccc2cc(C(C)C(=O)Oc3ccc(/C=C/C(=O)/C=C(O)/C=C/c4ccc(C)c(OC)c4)cc3OC)ccc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.52
HDAC2 Q92769 4/20 0.52
HDAC8 Q9BY41 4/20 0.52
GSK3B P49841 4/20 0.48
BACE1 P56817 3/20 0.47
JUN P05412 2/20 0.47
FOS P01100 1/20 0.47
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PTGS2 P35354 4/20 0.46
NFKB1 P19838 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PTGS1 P23219 2/20 0.45
AKR1C3 P42330 2/20 0.45
AKR1C2 P52895 2/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15340537 1.00 HDAC1 (0.52) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340538 1.00 HDAC1 (0.52) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15343965 0.91 HDAC1 (0.58) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15343963 0.91 HDAC1 (0.58) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15343964 0.91 HDAC1 (0.58) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340502 0.85 HDAC1 (0.53) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340503 0.85 HDAC1 (0.53) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340504 0.85 HDAC1 (0.53) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340526 0.83 HDAC1 (0.49) HDAC1HDAC2HDAC8GSK3BBACE1
SCHEMBL15340525 0.83 HDAC1 (0.49) HDAC1HDAC2HDAC8GSK3BBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130281520-A1 Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281520-A1 Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders HSD17B14, SORD, GPX4 HDAC1 2348/4885HDAC2 1662/4885HDAC8 2839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.